메뉴 건너뛰기




Volumn 27, Issue 3, 2007, Pages 238-240

Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab [1]

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; C REACTIVE PROTEIN; VASCULOTROPIN;

EID: 34748835859     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31814b273d     Document Type: Letter
Times cited : (74)

References (6)
  • 1
    • 25644449640 scopus 로고    scopus 로고
    • Pathophysiological consequences of VEGF-induced vascular permeability
    • Weis, SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005;437:497-504.
    • (2005) Nature , vol.437 , pp. 497-504
    • Weis, S.M.1    Cheresh, D.A.2
  • 2
    • 0028910230 scopus 로고
    • Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful
    • The Ischemic Optic Neuropathy Decompression Trial Research Group
    • The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-32.
    • (1995) JAMA , vol.273 , pp. 625-632
  • 3
    • 34147158700 scopus 로고    scopus 로고
    • Optic disc edema in non-arteritic anterior ischemic optic neuropathy
    • Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2007;245:1107-21.
    • (2007) Graefes Arch Clin Exp Ophthalmol , vol.245 , pp. 1107-1121
    • Hayreh, S.S.1    Zimmerman, M.B.2
  • 4
    • 33751247033 scopus 로고    scopus 로고
    • Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model
    • Gomez R, Gonzalez-Izquierdo M, Zimmermann RC, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 2006;147:5400-11.
    • (2006) Endocrinology , vol.147 , pp. 5400-5411
    • Gomez, R.1    Gonzalez-Izquierdo, M.2    Zimmermann, R.C.3
  • 5
    • 0034109535 scopus 로고    scopus 로고
    • Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy
    • Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2000;107:521-6.
    • (2000) Ophthalmology , vol.107 , pp. 521-526
    • Johnson, L.N.1    Guy, M.E.2    Krohel, G.B.3
  • 6
    • 0033404669 scopus 로고    scopus 로고
    • VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain
    • van Bruggen N, Thibodeaux H, Palmer JT, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999;104:1613-20.
    • (1999) J Clin Invest , vol.104 , pp. 1613-1620
    • van Bruggen, N.1    Thibodeaux, H.2    Palmer, J.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.